| Financial Year |
March 31 2023 |
| Monetary Funds |
1,064,208,506.90 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
34,310,004.37 |
| Accounts Receivable |
590,518,461.51 |
| Advances to Suppliers |
76,615,002.00 |
| Other Receivables |
15,554,410.11 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
605,207,275.23 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
3,141,389.99 |
| Other Current Assets |
31,228,700.48 |
| Total Current Assets |
2,421,924,372.11 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,614,671.80 |
| Long-term Equity Investment |
30,264,096.51 |
| Investment Properties |
710,730,690.13 |
| Fixed Assetes |
360,454,804.80 |
| Under-construction Projects |
6,239,114.68 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
274,811,099.38 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,100,202.61 |
| Deferred Income Tax Assets |
1,935,167.60 |
| Other Non-Current Assets |
3,758,760.51 |
| Sub-Total of Non-Current Assets |
1,766,572,604.21 |
| Total Assets |
4,188,496,976.32 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
204,352,476.18 |
| Accounts Payable |
542,912,712.73 |
| Accounts Received In Advance |
7,950,821.17 |
| Employee Compensation Payable |
29,634,581.03 |
| Taxes Payable |
10,229,410.90 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
33,832,535.52 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,175,680.86 |
| Other Current Liabilities |
4,034,043.44 |
| Sub-Total of Current Liabilities |
1,050,829,747.47 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,412,802.79 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
631,078.80 |
| Sub-Total of Non-Current Liabilities |
30,547,976.75 |
| Total Liabilities |
1,081,377,724.22 |
| Paid-In Capital(Or Share Stock) |
671,208,000.00 |
| Capital Surplus |
441,669,123.61 |
| Surplus Reserve |
-- |
| LESS:Treasury Stock |
71,405,036.91 |
| Undistributed Profits |
2,066,800,110.85 |
| Minority Stockholder's Interest |
12,503,134.55 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,094,616,117.55 |
| Owner's Equity（Stockholder's Equity） |
3,107,119,252.10 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,188,496,976.32 |
